BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 24928579)

  • 21. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
    Marembo T; Dube Mandishora R; Borok M
    Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
    Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK
    Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical Cancer Screening via Visual Inspection With Acetic Acid and Lugol Iodine for Triage of HPV-Positive Women.
    Wang S; Dang L; Liu S; Rezhake R; Yan H; Duan X; Zhang L; Zhang L; Zhang L; Su M; Guo F; Yan C; Liu M; Cao X; Sun M; Qiao Y; Zhao F
    JAMA Netw Open; 2024 Mar; 7(3):e244090. PubMed ID: 38551562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
    Jain BB; Adhikary T; Sadhukhan PC; Nandi A
    J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya.
    Huchko MJ; Sneden J; Sawaya G; Smith-McCune K; Maloba M; Abdulrahim N; Bukusi EA; Cohen CR
    Int J Cancer; 2015 Jan; 136(2):392-8. PubMed ID: 24889387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women.
    Baldur-Felskov B; Mwaiselage J; Faber MT; Kjaerem M; de la Cour CD; Munk C; Kahesa C; Iftner T; Rasch V; Kjaer SK
    Trop Med Int Health; 2019 Feb; 24(2):229-237. PubMed ID: 30444556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening approaches for cervical cancer in Mozambique in HIV positive and negative women.
    Sineque A; Catalao C; Ceffa S; Fonseca AM; Parruque F; Guidotti G; Massango C; Carrilho C; Bicho C; Rangeiro R; Orlando S; Marazzi MC; Lorenzoni C; Ciccacci F
    Eur J Cancer Prev; 2023 Sep; 32(5):431-437. PubMed ID: 37144587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer.
    Jeronimo J; Bansil P; Valdez M; Kang LN; Zhao FH; Qiao YL; Chen W; Zhang X; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
    J Low Genit Tract Dis; 2015 Jul; 19(3):220-3. PubMed ID: 25279978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies.
    Fokom-Domgue J; Combescure C; Fokom-Defo V; Tebeu PM; Vassilakos P; Kengne AP; Petignat P
    BMJ; 2015 Jul; 351():h3084. PubMed ID: 26142020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
    JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
    Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
    BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital.
    Muangto T; Chanthasenanont A; Lertvutivivat S; Nanthakomon T; Pongrojpaw D; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2016; 17(9):4409-4413. PubMed ID: 27797253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical determinants of a positive visual inspection after treatment with acetic acid for cervical cancer screening.
    Castle PE; Qiao YL; Zhao FH; Chen W; Valdez M; Zhang X; Kang LN; Bansil P; Paul P; Bai P; Peck R; Li J; Chen F; Jeronimo J
    BJOG; 2014 May; 121(6):739-46. PubMed ID: 24575872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of visual Inspection With Acetic Acid for Cervical Cancer Screening as Compared to Human papillomavirus Deoxyribonucleic acid Testing Among Women With HIV in Ethiopia: A Comparative Cross-sectional Study.
    Bogale AL; Teklehaymanot T; Kassie GM; Medhin G; Ali JH; Belay NB
    Cancer Control; 2022; 29():10732748221114980. PubMed ID: 35829643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study.
    Zhang HY; Tiggelaar SM; Sahasrabuddhe VV; Smith JS; Jiang CQ; Mei RB; Wang XG; Li ZA; Qiao YL
    Asian Pac J Cancer Prev; 2012; 13(1):91-6. PubMed ID: 22502720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women.
    Kuhn L; Wang C; Tsai WY; Wright TC; Denny L
    AIDS; 2010 Oct; 24(16):2553-61. PubMed ID: 20706107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
    Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
    Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.
    Ramogola-Masire D; McGrath CM; Barnhart KT; Friedman HM; Zetola NM
    Int J Gynecol Pathol; 2011 Nov; 30(6):591-6. PubMed ID: 21979597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of human papillomavirus-based cervical cancer screening strategies in Tanzania among women with and without HIV.
    Kahesa C; Thomsen LT; Linde DS; Mchome B; Katanga J; Swai P; Manongi R; Kjaerem M; Iftner T; Waldstrøm M; Mwaiselage J; Rasch V; Kjaer SK
    Int J Cancer; 2023 Feb; 152(4):686-696. PubMed ID: 36093587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
    Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
    J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.